Once-a-day stimulant is safe for ADHD, can be used after 1 year

Published Date: 13 Mar 2023

New research shows that once-daily speech-stimulating medications for the treatment of ADHD in people age 6 and older are safe and effective after one year of pain treatment.

Read Full News

Latest News

Deep Brain Stimulation Tied to Lower Mortality in PD

Deep brain stimulation is linked to reduced risks for mortality and institutionalization, and lower healthcare costs in adults with Parkinson’s disease, a study shows.

Ask the IIM Experts: From Immune Mechanisms to Emerging Therapies - A Comprehensive Update on Idiopathic Inflammatory Myopathies

Ask the IIM Experts: From Immune Mechanisms to Emerging Therapies - A Comprehensive Update on Idiopathic Inflammatory Myopathies

What Is Causing This Case of Sudden Aphasia?

Clues come from a kidney injury, encephalop­athy, and drug dosing error

Neuropathy After Recreational Use of Laughing Gas

Clinicians should be aware of adverse effects of this increasingly popular drug

Vitamin C and the Brain; Invisible MS Lesions Revealed; Profound Autism Definition

News and commentary from the world of neurology and neuroscience

Alzheimer's Biomarkers Change After Tuberculosis Vaccination

BCG vaccine altered immune responses and modified amyloid-beta, study shows

Todays Updates

AI-Driven Biomarker Predicts Prostate Cancer Outcomes

The tool, based on histology only, may help identify patients most likely to benefit from triplet therapy.

Community Oncology Well Suited for Advanced Cancer Patients

Experts tout common characteristics of local physician practices that are beneficial to those with advanced disease.

Todays Updates

AI-Driven Biomarker Predicts Prostate Cancer Outcomes

The tool, based on histology only, may help identify patients most likely to benefit from triplet therapy.

Community Oncology Well Suited for Advanced Cancer Patients

Experts tout common characteristics of local physician practices that are beneficial to those with advanced disease.

Latest News

Deep brain stimulation is linked to reduced risks for mortality and institutionalization, and lower healthcare costs in adults with Parkinson’s disease, a study shows.

Ask the IIM Experts: From Immune Mechanisms to Emerging Therapies - A Comprehensive Update on Idiopathic Inflammatory Myopathies

Clues come from a kidney injury, encephalop­athy, and drug dosing error

Clinicians should be aware of adverse effects of this increasingly popular drug

News and commentary from the world of neurology and neuroscience

BCG vaccine altered immune responses and modified amyloid-beta, study shows

News All Time

Report: Law Firms Cheated in Filing Claims With NFL's Concussion Settlement Fund

The fund was meant to last for 65 years

Ebola's Brain Effects Persist More Than 7 Years After Infection

Many survivors still had neurologic symptoms, most notably memory loss

Alzheimer's and Psilocybin; Migraine and Driving; What New MS Criteria Reveal

News and commentary from the world of neurology and neuroscience

Hospital's Brain Tumor Cluster; Princess's Lung Transplant; Plastic Surgery Deaths

Health news and commentary gathered by MedPage Today staff

Brain Disorders and TBI May Fuel Each Other

Two-way relationships with traumatic brain injury emerge in a large study of veterans

FDA Reverses Course on Neuro Drugs; Omega-3s and Dementia; Brain Death Test Lawsuit

News and commentary from the world of neurology and neuroscience

First State Bans Paraquat, a Weed Killer Linked to Parkinson's Disease

The herbicide is used widely in the U.S. but banned in China and Europe

ALS Testing Expected to Drive Sharp Rise in Clinic Visits

Genetic screening in the wake of new therapies will identify more at-risk relatives

Study Suggests No Link Between Prenatal Tylenol and Risks for Autism, ADHD

Research shows the power of negative control analyses

NFL Star Diagnosed With ALS at 39; 'No Surprises' Windfall; Arizona Plague Scare

Health news and commentary gathered by MedPage Today staff

Brain Worm Lesions Mimicking Cancer; Midlife Dementia Marker; Ovarian Reserve and MS

News and commentary from the world of neurology and neuroscience

Trump Actions Signal Move Toward Institutionalizing Disabled People, Advocates Warn

The Education Department announced it would offload oversight of special education to HHS

Persistent Double Vision Follows Insidious Onset of Ptosis in Healthy Man

High-resolution MRI aids in differential diagnosis

Man Goes Blind After Binging on Booze and Crystal Meth

Look beyond uremia and acidosis for rare cause of lentiform fork sign on MRI, authors say

Emails Reveal How RFK Jr. Empowered a Lone CDC Scientist

William Thompson made demands of and criticized CDC leadership

Off-Label Drug Proves Its Mettle in Relapsing Multiple Sclerosis

Rituximab and ocrelizumab go head to head in randomized trial

Recommended News For You

According to a study by Amrita Hospital in Kochi, cancer mortality is rising among Indian women while declining for men.

CAR-T Warning for Secondary Malignancies: Warranted or Not?

Parkinson patient's gait is restored by a spinal cord stimulator.

Specific suicidal patterns mark the highest risk.

Zebrafish models offer fast, effective guidance for personalized therapies for kids with high-risk cancer

Researchers discover that children who survive cancer have socioeconomic challenges.

FDA Expands Use of T-DXd in Early HER2+ Breast Cancer

Recommended Articles For You

Breast Cancer Recovery: Fashion, Function, and Healing Beyond Scars 

Practical Applications in Hematology Across Clinical Settings 

Unveiling the Mystery Behind Lymphovascular Invasion 

Childhood Cancer Survivorship and Long-Term Organ Health 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

TRK Inhibitor Active in Treatment-Refractory Glioblastoma

2.

Hair Growth After Cancer; 'Global' Early-Onset CRC; Retifanlimab Boosts OS in NSCLC

3.

Omitting Biopsy After Negative MRI Halves Diagnoses of Insignificant Prostate Cancer

4.

Alkem introduces cetuximab under the trade name Cetuxa in India.

5.

A specific drug combination is being tested in a clinical trial for the deadly brain cancer glioblastoma.

1.

Lentigo Maligna Melanoma: Everything You Need To Know about This Skin Cancer

2.

Unlocking the Potential of SCD: A Comprehensive Guide to Diagnosis and Treatment

3.

The Benefits and Side Effects of Vidaza Syndrome 

4.

Exploring Innovative Approaches to Esophageal Cancer Treatment

5.

Understanding the Role of CA 19-9 in Cancer Diagnosis and Treatment

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC

2.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII

3.

Targeting Oncologic Drivers: A New Approach to Lung Cancer Treatment

4.

Navigating the Complexities of Ph Negative ALL - Part XV

5.

Navigating the Complexities of Ph Negative ALL - Part VIII

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot